S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months

Humana (HUM) Stock Price, News & Analysis

$481.62
+1.32 (+0.27%)
(As of 12/8/2023 08:57 PM ET)
Compare
Today's Range
$475.06
$482.69
50-Day Range
$476.95
$524.24
52-Week Range
$423.29
$546.86
Volume
1.08 million shs
Average Volume
1.18 million shs
Market Capitalization
$59.29 billion
P/E Ratio
19.97
Dividend Yield
0.74%
Price Target
$590.28

Humana MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.73 Rating Score
Upside/​Downside
22.6% Upside
$590.28 Price Target
Short Interest
Healthy
2.21% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
0.80mentions of Humana in the last 14 days
Based on 26 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.10%
From $28.28 to $31.42 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.14 out of 5 stars

Medical Sector

17th out of 942 stocks

Hospital & Medical Service Plans Industry

2nd out of 11 stocks


HUM stock logo

About Humana Stock (NYSE:HUM)

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

HUM Stock Price History

HUM Stock News Headlines

Mega merger in the works? Humana, Cigna explore big deal (HUM)
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
US health insurer Cigna scraps deal to buy Humana
US health insurer Cigna scraps deal to buy Humana -WSJ
Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback
Short Interest in Humana Inc. (NYSE:HUM) Decreases By 5.6%
See More Headlines
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/27 Dividend
9/28/2023
Dividend Payable
10/27/2023
Last Earnings
11/01/2023
Today
12/11/2023
Ex-Dividend for 1/26 Dividend
12/28/2023
Fiscal Year End
12/31/2023
Dividend Payable
1/26/2024
Next Earnings (Estimated)
2/07/2024

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Sector
Medical
CUSIP
44485910
Employees
67,100
Year Founded
1961

Price Target and Rating

Average Stock Price Target
$590.28
High Stock Price Target
$652.00
Low Stock Price Target
$541.00
Potential Upside/Downside
+22.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
15 Analysts

Profitability

Net Income
$2.81 billion
Pretax Margin
3.81%

Debt

Sales & Book Value

Annual Sales
$92.87 billion
Cash Flow
$32.11 per share
Book Value
$121.41 per share

Miscellaneous

Free Float
122,717,000
Market Cap
$59.29 billion
Optionable
Optionable
Beta
0.55

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Should I Buy Humana Stock? HUM Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Humana was last updated on Sunday, December 10, 2023 at 7:03 PM.

Pros

Here are some ways that investors could benefit from investing in Humana Inc.:

  • Humana Inc. is a well-established health and well-being company in the United States.
  • It operates through two segments, Insurance and Healthcare Services, providing a diversified range of products and services.
  • Humana Inc. has a strong track record of financial performance and has consistently delivered positive results.
  • The company offers innovative healthcare solutions and is constantly adapting to the changing needs of the market.
  • One reason to invest in Humana Inc. is its current stock price, which can provide potential returns for investors.

Cons

Investors should be bearish about investing in Humana Inc. for these reasons:

  • Humana Inc. faces regulatory risks and uncertainties in the highly regulated healthcare industry.
  • The company operates in a competitive market with other major players, which may impact its market share and profitability.
  • Changes in government policies and healthcare regulations can have a significant impact on Humana Inc.'s business operations.
  • Investing in healthcare companies involves inherent risks related to the unpredictable nature of healthcare trends and developments.
  • While Humana Inc. has a strong presence in the United States, its international operations may face challenges and risks.














HUM Stock Analysis - Frequently Asked Questions

Should I buy or sell Humana stock right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HUM shares.
View HUM analyst ratings
or view top-rated stocks.

What is Humana's stock price target for 2024?

15 Wall Street analysts have issued twelve-month price targets for Humana's shares. Their HUM share price targets range from $541.00 to $652.00. On average, they predict the company's share price to reach $590.28 in the next year. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for HUM
or view top-rated stocks among Wall Street analysts.

How have HUM shares performed in 2023?

Humana's stock was trading at $512.19 on January 1st, 2023. Since then, HUM stock has decreased by 6.0% and is now trading at $481.62.
View the best growth stocks for 2023 here
.

Are investors shorting Humana?

Humana saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 2,710,000 shares, a drop of 5.6% from the October 31st total of 2,870,000 shares. Based on an average daily volume of 1,030,000 shares, the days-to-cover ratio is presently 2.6 days. Currently, 2.2% of the company's stock are short sold.
View Humana's Short Interest
.

When is Humana's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our HUM earnings forecast
.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) announced its quarterly earnings data on Wednesday, November, 1st. The insurance provider reported $7.78 EPS for the quarter, beating analysts' consensus estimates of $7.15 by $0.63. The insurance provider had revenue of $26.42 billion for the quarter, compared to the consensus estimate of $25.57 billion. Humana had a trailing twelve-month return on equity of 21.03% and a net margin of 2.95%. The firm's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.88 earnings per share.
Read the conference call transcript
.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Tuesday, October 31st. Investors of record on Friday, December 29th will be paid a dividend of $0.885 per share on Friday, January 26th. This represents a $3.54 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Thursday, December 28th.
Read our dividend analysis for HUM
.

Is Humana a good dividend stock?

Humana (NYSE:HUM) pays an annual dividend of $3.54 per share and currently has a dividend yield of 0.74%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 14.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.27% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY23 earnings guidance on Friday, December, 1st. The company provided earnings per share (EPS) guidance of at least $28.25 for the period, compared to the consensus estimate of $28.28.

What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Who are Humana's major shareholders?

Humana's stock is owned by many different institutional and retail investors. Top institutional investors include Wellington Management Group LLP (5.47%), FMR LLC (4.05%), Morgan Stanley (1.66%), Ameriprise Financial Inc. (1.24%), Northern Trust Corp (1.08%) and Newport Trust Company LLC (1.06%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends
.

How do I buy shares of Humana?

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Humana have any subsidiaries?
The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.
Read More
This page (NYSE:HUM) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -